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The placenta is the principal regulator of the in utero environment, and disruptions to this environment can result in
adverse offspring health outcomes. To better characterize the impact of in utero perturbations, we assessed the
influence of known environmental pollutants on the expression of microRNA (miRNA) in placental samples collected
from the National Children’s Study (NCS) Vanguard birth cohort. This study analyzed the expression of 654 miRNAs in
110 term placentas. Environmental pollutants measured in these placentas included dichlorodiphenyldichloroethylene
(DDE), bisphenol A (BPA), polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs), arsenic (As),
mercury (Hg), lead (Pb), and cadmium (Cd). A moderated t-test was used to identify a panel of differentially expressed
miRNAs, which were further analyzed using generalized linear models. We observed 112 miRNAs consistently expressed
in >70% of the samples. Consistent with the literature, miRNAs located within the imprinted placenta-specific C19MC
cluster, specifically mir-517a, mir-517c, mir-522, and mir-23a, are among the top expressed miRNA in our study. We
observed a positive association between PBDE 209 and miR-188–5p and an inverse association between PBDE 99 and
let-7c. Both PCBs and Cd were positively associated with miR-1537 expression level. In addition, multiple let-7 family
members were downregulated with increasing levels of Hg and Pb. We did not observe DDE or BPA levels to be
associated with placental miRNA expression. This is the first birth cohort study linking environmental pollutants and
placental expression of miRNAs. Our results suggest that placental miRNA profiles may signal in utero exposures to
environmental chemicals.
Introduction
The intrauterine period is defined by gene-environment inter-
actions, making it a critical window of susceptibility in which
perturbations have the potential to impact both fetal develop-
ment and health outcomes later in life. The placenta is the princi-
pal regulator of the intrauterine environment, serving as the
maternal-fetal interface, playing a vital role in the appropriate
growth and development of the fetus, facilitating nutrient
exchange and waste removal, providing immune protection, and
mediating metabolic and endocrine activity on behalf of the
developing fetus. 1-5
Exogenous environmental agents, such as metals and organic
pollutants, have been shown to cross and accumulate in the pla-
centa with the potential to disrupt processes involved in normal
development. 6,7 For example, in utero exposures to metals, such
as arsenic (As), mercury (Hg), lead (Pb), and cadmium (Cd), as
well as organic pollutants, such as polychlorinated biphenyls
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(PCB), polybrominated diphenyl ethers (PBDE), and dichlorodi-
phenyldichloroethylene (DDE), have been associated with devel-
opmental delays. 8-11
MicroRNAs (miRNAs) are labile gene expression regulatory
elements that may mediate gene-environment interactions. They
are short (21–24 nucleotides), single-stranded RNA molecules
that do not code for proteins themselves but are able to control
the expression of genes that do.12 They regulate gene expression
posttranscriptionally by binding to the 30-untranslated region of
their target mRNA and consequently attenuating protein transla-
tion. This repression of gene expression is mediated by either
translational repression or mRNA degradation, based on the
degree of complementarity to target mRNA sequences.13 As only
partial complementarity is needed, a single miRNA can bind
multiple mRNA transcripts and each mRNA can be bound be
multiple miRNAs. In this way, miRNAs are able to regulate
diverse gene networks, including cell proliferation, apoptosis,
and differentiation.14
Given the rising concern over the impact of in utero exposures
to environmental pollutants, there is an increasing interest to
determine whether miRNAs can signal perturbations to the intra-
uterine environment. In this study, we profiled placental miRNA
using samples collected as part of the National Children’s Study
(NCS) to assess associations between miRNA expression levels




The demographic characteristics of the study population are
shown in Table 1. As indicated in the table, the study population
consists of women with normal term (37 weeks) vaginal deliv-
eries with placenta samples collected on average within 1 h.
The nanoString human miRNA codeset contains 654 miRNA
targets, out of which 112 miRNAs were considered to be
“expressed” in the placenta using our stringent criteria indicated
in the Materials and Methods section. In line with what has been
previously reported, placenta-specific miRNAs, particularly those
located within the imprinted C19MC cluster, predominate
among the expressed miRNAs of our study (Supplementary
Table 1). Additionally, similar to previous reports, the most
abundantly expressed miRNA is the C19MC derived miR-
517a.15 Using LIMMA analysis, we did not detect any differen-
ces in miRNA expression by the gender of newborns, maternal
age, or gestational age.
Influence of organic pollutants on placental miRNA profile
The organic pollutants investigated were PBDEs, PCBs,
DDE, and BPA. These agents were selected based on the known
risk of early developmental defects associated with these chemi-
cals and/or their ability to cross the placental barrier and accumu-
late in the placenta to detectable levels.16–18 The mean placental
levels detected in our study population are shown in Table 1.
While the detected placental levels of these pollutants were
relatively low, they fall in line with previous findings in western
industrialized nations.19–22
While 10 PBDE congeners were measured in the placenta, we
focused our analysis on the low brominated (47, 99) and high
brominated (153, 209) congeners previously reported to be the
most abundantly detected in the placenta,23,24 as well as total
PBDE (summing all the congeners). Using generalized linear
models, we observed a positive association between the high-bro-
minated congener 209 and miR-188–5p (Ptrend D 0.01) and an
inverse association between the low-brominated congener 99 and
let-7c (Ptrend D 0.04) (Fig. 2). No association was observed
between total PBDE and any miRNA.
Among the 32 PCB congeners measured in the placenta, we
focused on the congeners 52, 101, 105, 118, and 153, previously
reported to be the most abundantly detected congeners in the
placenta, as well as total PCB (summing all the congeners).25
Generalized linear models indicated a significant positive linear
trend between PCB congeners 52, 101, and total PCB and miR-
1537 expression (Fig. 3). It is important to point out that PCB
congeners 52 and 101 are highly correlated with one another
(r D 0.96, P < 0.01) as well as with total PCB, with correlation
coefficients of 0.95 and 0.96, respectively (P < 0.01). We did
not find any association between miRNA expression and the level
of DDE and BPA measured in the placenta.






Collection time (hours) 1.1 1.1
Gestational age (weeks) 39.6 1.0
Median Min-max
PBDE congeners (pg/g)
PBDE 47 35.0 5.4–302.2
PBDE 99 12.0 1.0–126.0
PBDE 153 16.7 2.7–251.3
PBDE 209 59.4 14.6–612.5P
10 PBDEs* 170.1 53.5–737.4
PCB congeners (pg/g)
PCB 52 38.6 13.7–94.8
PCB 101 79.7 24.9–244.5
PCB 105 22.7 7.0–163.3
PCB 118 63.9 20.6–313.2
PCB 153 43.2 11.9–150.9
PCB 180 18.8 3.4–85.3P






DDE (pg/g) 180.1 76.2–4157.0
BPA (pg/g) 264.9 6.3–12979.7
*
P
10 PBDEs include PBDEs 28, 47, 66, 85, 99, 100, 153, 154, 183, 209;
P
32
PCBs include PCBs 8, 28, 37, 44, 49, 52, 60, 66, 70, 74, 77, 82, 87, 99, 101, 105,
114, 118, 126, 128, 138, 153, 156, 158, 166, 169, 170, 179, 180, 183, 187, and
189.
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Figure 1. Study Design.
Figure 2. Influence of PBDE congeners on placental miRNA profile (n D 104). (A) Association between let-7c and PBDE 99 (B) Association between
miR-188–5p and PBDE 209. Error bars represent standard error interval. P-value is based on generalized linear model.
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Influence of metals on placental miRNA profile
An array of total metal levels, toxic and essential, were mea-
sured in a subset (n D 43) of placenta tissues collected for the
NCS. In this investigation, we focused on the known toxic met-
als, i.e., As, Pb, Hg, and Cd, previously shown to have detrimen-
tal effects on development. Due to the reduced sample size and
non-normal distribution of metal levels detected, we dichoto-
mized the study samples at the median level detected in the pla-
centa. As shown in Figure 4, we observed that high Hg level was
associated with reduced expression of a large number of miRNAs
including miR-151–5p, miR-10a, miR-193b, miR-1975, miR-
423–5p, miR-520d-3p, miR-96, miR-526aCmiR-518d-
5pCmiR-520c-5p, and most prominently, a large number in the
let-7 family (i.e., let-7a, let-7b, let-7c, let-7d, let-7g, and let-7i).
The levels of these let-7 isoforms were observed to be highly cor-
related in the placenta (r D 0.65–0.97). Meanwhile, high placen-
tal Pb levels were associated with the reduced expression of 4
miRNAs (let-7f, miR-146a, miR-10a, and miR-431) and an
increased expression of miR-651. Interestingly, miR-190b was
down regulated by both Pb and Hg. Moreover, high placental
Cd levels were associated with increased miR-1537 expression,
similar to what was observed with PCBs. We did not find any
association between miRNA expression and the level of As mea-
sured in the placenta.
Discussion
In the current study, we assessed the global miRNA expression
profile of 110 human placentas collected from the NCS. The
study focuses on placentas from term, clinically normal pregnan-
cies with vaginal delivery free of pathological complications. The
number of miRNA considered to be consistently “expressed” in
this study is in line with recent published studies,26 though other
studies have reported up to 600 detectable miRNAs in placentas
using various different platforms.27-29 Such discrepancies may
largely be driven by different criteria of what is considered
“expressed." It may also reflect platform-specific differences. As
Figure 3. Influence of PCB congeners on placental miRNA profile (n D 105). (A) Association between miR-1537 and PCB 52 (B) Association between miR-
1537 and PCB 101 (C) Association between miR-1537 and total PCB. Error bars represent standard error interval. P-value is based on generalized linear
model.
796 Volume 10 Issue 9Epigenetics
miRNA expression profiles are tissue-specific and the placenta is a
known composite of heterogeneous cell types stemming from
fetal and maternal origin, the discrepancy may also arise due to
differences in tissue sampling.28
In line with previous reports, miRNAs expressed in the pla-
centa from our study largely cluster in distinct chromosomal
locations, namely the chromosome 19 miRNA cluster
(C19MC).30 MiRNAs located in this cluster have been shown to
be abundantly expressed in the placenta while lowly expressed in
other tissues.31 Additionally, this cluster overlaps with a pater-
nally expressed imprinted region.32 Imprinted loci belonging to
these domains are typically activated at critical developmental
stages and involved in controlling cell differentiation and fate in
the embryonic growth of placenta tissue.33,34
Our study is one of the few to investigate the potential effects
of environmental pollutants on miRNA expression in humans.
Our results clearly demonstrate such effects in which both organ-
ics and metal- levels are associated with miRNA expression in
placenta. Hg shows the most striking effect, with a large number
of miRNAs downregulated with increasing level of Hg. Reported
postnatal outcomes due to prenatal Hg exposure include birth
defects and learning and memory deficits,35,36 with common
sources of exposure including maternal fish intake37,38 and dental
amalgams.39 To date, the only epidemiologic study reporting
changes in miRNA expression with varying levels of Hg exposure
focused on urinary levels in adolescents.40
In our study, Pb was also found to be associated with changes
in expression of several miRNAs. While exposure to Pb sharply
decreased over the last few decades, residual exposure from lead
painting, piping and legacy industrial sources remains of concern.
Low levels of prenatal exposure continue to show associations
with cognitive deficits.41–43 Our study is the first to report on the
impact of prenatal Pb levels on the placental miRNA expression
profile. Our finding showing a negative correlation between
miR-146a expression and Pb exposure is in agreement with the
findings reported in an occupational study of Pb exposure
assessed in peripheral blood leukocytes.44
We also observed several instances of individual miRNAs
responding to multiple environmental pollutants. For example,
members of the let-7 miRNA family were influenced by Hg, Pb,
and PBDE 99. Also of note is that all let-7 miRNAs were down
regulated with increasing exposure. This family of highly con-
served miRNAs has been established to play a critical role in early
development, primarily by driving differentiation.45–47 Deregu-
lation of these miRNAs has been linked with several cancers.48
Furthermore, a role in placental development is indicated by a
study showing that let-7 family members are up-regulated in 3rd
trimester placenta samples compared to 1st trimester placenta
samples.49 Hence, the observed downregulation of let-7 isoforms
in term placenta with increasing toxicant levels may indicate a
state of disrupted placental development in response to chemical
exposures.
Additionally, miR-190b was differentially expressed in the
presence of Hg and Pb. The expression of this miRNA was
recently reported to regulate Neuregulin 3-mediated inhibitory
control processes of the amygdala.50 As dysregulation of
inhibitory control is a marker of several mental health disorders,
including ADHD, these findings are in line with behavioral
defects reported in relation to in utero Hg and Pb exposures.51–54
Similarly, miR-1537 was differentially expressed in the pres-
ence of PCB congeners and Cd. While few studies have reported
on this miRNA, it has been previously described that miR-1537
is located in a region commonly deleted in a subset of high-risk
neuroblastoma cases.55 Few epidemiological studies have
reported on the impact of either Cd, a contaminant of growing
concern due to its presence in cigarette smoke and electronic-
waste, or of PCBs, a persistent class of chemical previously used
as a flame retardant and plasticizer, on miRNA expression. While
associations between these exposures and alterations in miRNA
expression were reported in these studies, the findings were based
on the analysis of peripheral blood leukocytes from occupation-
ally-exposed adults.44,56 The current study is the first to report
the impact of prenatal Cd and PCB levels on the placental
miRNA expression profile.
Neither BPA nor DDE induced changes in miRNA expres-
sion profiles. The fact that not all environmental agents elicit
alterations in the placental-miRNA profile suggests an inherent
specificity in the sensitivity/responsiveness of miRNAs to envi-
ronmental pollutants.
The findings presented in this study indicate plausible interac-
tions between environmental pollutants and placental epigenetic
markers. The observed correlated changes in miRNA expression
and environmental pollutant levels could reflect an exposure-
induced perturbation on miRNA expression levels. For example,
environmental pollutants could interact with the miRNA biosyn-
thesis machinery, thereby directly inducing changes in miRNA
expression levels.57,58 Alternatively, altered miRNA expression
levels could reflect a host-induced adaptive response, including
the upregulation of DNA repair and detoxification genes, to
counteract maladaptive effects of environmental pollutants on
cellular processes.59 For example, the top Targetscan-derived
mRNA targets of miR-146a include TRAF1 and IRAK1, genes
involved in the toll-like receptor pathway. Hence, the downregu-
lation of miR-146a we observed with increasing levels of Pb levels
could indicate a host cell-mediated immune activation in
response to these environmental pollutants.
While suggestive, the observed associations between environ-
mental pollutants and miRNA expression levels warrants further
study due to the inherent limitations in the current study design.
Outcome variables available in this population were few, and the
impact of other exposure-related differences in miRNA expres-
sion could not be assessed. Additionally, the metal-related find-
ings are exploratory with limited sample size. Furthermore,
similar to the congener-specific effects of organics observed in
this study, the impact of metals may also depend upon the spe-
cific metal compound, such as methyl mercury vs. total mercury.
More refined analyses are warranted that capture these species-
specific effects.
As is the case for all biospecimens with a heterogeneous cell-
type composition, placental miRNA content can vary based on
the sampling method implemented. In the current study, consis-
tency was maintained by removing the maternal decidua prior to
www.tandfonline.com 797Epigenetics
sampling and restricting biopsies to villous tissues free from
infarcts and calcifications. This sampling strategy minimizes, but
does not prevent, the potential for non-random variability in
miRNA content across the samples.
Lastly, one important issue that warrants careful consideration
is concerning “multiple comparisons.” In this study, we used a
step-wise approach to detect gene-environment associations.
First, we conducted a moderated t-test across our panel of
expressed miRNAs to identify candidate loci that are differen-
tially expressed between the 1st vs. 4th quartiles of environmental
exposures, which were then further analyzed with generalized lin-
ear models. The candidates selected for further analysis in the first
step were chosen based on a cut-off value of P < 0.05. Given that
the number of miRNA (n D 112 ) included in our analysis
increases the likelihood of false positive findings (Type I error), a
more stringent cut-off accounting for the multiple comparisons
may be warranted. However, there is continuing debate on
whether/when/how multiple comparisons should be taken into
account.60 When evaluating results of molecular epidemiology
studies, statistical power and the priority of the tested hypothesis
also need to be taken into account, in addition to the magnitude
of the P value. Conventional multiple comparison adjustment
methods, such as the Bonferroni method, may safeguard false
positive findings, but at the same time increase Type II error
(false negative) and reduce sensitivity.61 Nevertheless, results
from our study need to be interpreted with caution and warrant
replication in other population studies.
In summary, this study surveys the miRNA profile in human
placenta and reported environmental exposure-related differences
in expression of miRNA with a moderate sample size. Our find-
ings suggest the potential of miRNAs to serve as markers of pre-
natal environmental exposures. We observed global changes in
Figure 4. miRNAs significantly differentially expressed due to toxic metal exposure (n D 43). (A) Hg (B) Pd (C) Cd. Circle/triangle and error bar represent
mean and standard error, respectively.
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miRNA expression levels related to Hg, Pb, and Cd exposures,
while PBDE and PCB congeners were associated with specific
miRNAs. No changes in miRNA expression were observed in
association with BPA or DDE exposure. Furthermore, a single
miRNA (such as miR-190b) may be sensitive to multiple expo-
sures. Planned studies will include generating a transcriptome
profile of these samples and evaluating the interrelationship
between the miRNA and mRNA profile using a systems biology
approach to provide further insight on the role of the placental
epigenomics in human reproduction and development.
Materials and Methods
Sample collection
This study is a part of NCS formative research (Project LOI2-
BIO-18). Placenta samples were collected from study locations as
part of the NCS Vanguard study, a planned large-scale epidemio-
logical cohort study of environmental influences on child health
and development. Placenta samples included in the current study
were collected from 13 counties across the US. Written informed
consent was obtained from all participants. The study protocol
was reviewed and approved by the Office of Human Research
Protections registered Institutional Review Boards.
All placental specimens were excised from grossly normal areas
of the villous parenchyma, excluding the deciduas basalis and
chorionic plate. Sampling occurred at the participating collection
hospital and a second time at the University of Rochester’s Pla-
cental Processing Center (URPPC). Dates and times were
obtained for each collection. All samples were packaged in a stan-
dardized manner and shipped overnight to the URPPC.
Tissue Isolation for Nucleic Acid Studies. Forty to 60 mg of vil-
lous tissue was obtained for nucleic acid extraction, by first rins-
ing twice in sterile RNAse/DNAse free phosphate buffered
saline, lightly macerating the tissue with sterile, fine-tipped scis-
sors and then placing the tissue in 5 ml of RNALater (Life Tech-
nologies, AM7024) and maintained at 4C. All samples were
labeled with a specific study identification code, which blinded
investigators to the collection site and collection time. These
sample codes were maintained at the URPPC.
Tissue samples for other environmental analyses. Five to 10 g of
villous tissue was collected as above and stored in acid-washed,
BPA-free 50-mL tubes using plastic (non-metallic) disposable
forceps. Placental sample collection (time 0) occurred within
0–6 h after birth, and samples were stored on dry ice or at
¡80C until shipped on dry ice to the URPPC, where they were
stored at ¡80C.
RNA extraction
Nucleic acids (e.g., genomic DNA and total RNA, micro-
RNAs) were extracted from the samples stored in RNALater at
the URPPC using an AllPrep DNA/RNA extraction kit accord-
ing to manufacturer’s instruction (Qiagen, 80204). Genomic
DNA and total RNA samples were quantified using a microplate
spectrophotometer (Biotek, Winooski, VT). Coded total RNA
samples were obtained frozen from the URPPC.
Study Population
The study design is depicted in Figure 1. A total of 210 pla-
centas from singleton deliveries were collected. In a pilot study
we determined the temporal variability in placental miRNA
expression level based on repeat biopsies sampled at varying
time-points.62,63 Based on our findings from this prior study, we
limited our analysis to placenta samples that were collected
within 6 h of delivery to ensure miRNA stability (n D 189).
Basic clinical information, including infant gender, gestational
age, delivery method, and absence of any pathological abnormali-
ties, was available for 141 subjects. Within this subset, we
restricted our analysis to vaginal deliveries with a gestational age
of 37 – 42 weeks (n D 110).
miRNA profiling
miRNA expression profiling was conducted using the
nCounter Analysis System (Nanostring technologies, Seattle,
WA) following the manufacturer’s protocol. Briefly, 100 ng total
RNA were assayed using the nCounter human miRNA expres-
sion assay. Samples were prepared by ligating miRtags onto the
3’ end of mature miRNAs to normalize the melting temperature
of the miRNAs and to facilitate the use of the dual probe system.
Following the removal of excess tags by restriction digestion at
37C, the tagged miRNAs were hybridized overnight at 65C
with reporter probes containing color-coded barcodes unique to
each target and biotinylated capture probes. Excess reporter and
capture probes were sequentially removed using magnetic bead
based purification on the nCounter Prep Station II. Following
immobilization in the sample cartridge, target molecules were
quantified based on the fluorescence of the reporter probes using
an nCounter Digital Analyzer.
Chemical analysis
PBDEs, PCBs, DDE
Analytic assessment of the chemicals has been detailed in a
previous publication.22 Placenta tissue was freeze-dried, manually
ground, and extracted using optimized matrix solid phase disper-
sion (MSPD) method.64 Sample cleanup was accomplished using
a multi-layer silica gel column. PCB congeners and DDE were
analyzed using an Agilent 7890A gas chromatograph coupled to
an Agilent 7000 tandem mass spectrometer equipped with an
electron impact ionization source. PBDE congeners were ana-
lyzed using an Agilent 6890 gas chromatograph connected to an
Agilent 5973 mass spectrometer (MS) with electron capture neg-
ative ionization mode.
BPA
Placental samples were ethyl-acetate extracted 2 times, dried
under N2 stream for 1 h and reconstituted with 50% aqueous
acetonitrile. Following centrifugation to remove any remaining
residual debris, samples were loaded onto a liquid chromatogra-
phy-tandem mass spectrometry (LC-MS/MS) system for analysis
(UltiMate 3000 (Thermo Scientific, Somerset, NJ), micrOTOF
II (Bruker Daltonics, Billerica, MA)). Data from the LC-MS/MS
run was uploaded to the system’s “Quant Analysis” software
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package (Bruker, Daltonics) to process and quantitate BPA levels.
A series of calibration standards was included for quantitation.
Quality control samples were run alongside each batch of 10
samples to verify consistent instrument performance.
Metals
All sample preparation for metal analysis was conducted in a
class 100 trace metal free clean laboratory facility. Prior to analy-
sis, all samples were thawed at room temperature for approxi-
mately 4 h. An aliquot of 1 g from each sample specimen was
then individually selected for inductively coupled plasma mass
spectrometry (ICP-MS) analysis of metal concentration. Sample
aliquots were selected by cutting the placental tissue with a
ceramic knife that was cleaned between each sample and blank
verified at least once per sample preparation day. Compound spe-
cific metals analyses were measured by either high-performance
liquid chromatography (HPLC)-ICP-MS65,66 or GC-ICP-MS
methodologies.
For metal concentrations, each sample was weighed using a
calibrated mass balance and the wet tissue weight was recorded.
Each sample was then dried for up to 48 h at 60C in a vacuum
oven. After drying, samples were re-weighed to determine the dry
weight. Individual samples were then masticated with a trace
metal free ceramic mortar and pestle, which was cleaned between
each sample. After mastication, sample weights were re-recorded
to § 0.001 mg, and the tissue was digested in Teflon vessels
using concentrated (15.9 mol/L) ultra-pure nitric acid (HNO3)
at 70C for approximately 6 h or until digestion was complete as
previously described.67 Samples were then digested under tem-
perature- and pressure- controlled conditions using closed SCP
Science Class A digestion tubes and a SCP Science 48-sample
digestion block with DigiProbe temperature control. After cool-
ing, the remaining solution was baked for approximately 8 h (or
until dry) at 50C to decant excess nitric acid. Residual dried
material was then re-digested with »0.5 mL of ultra-pure
HNO3.
Statistical analysis
The NanoString Norm package68 was used to normalize
nCounter data. Code counts were normalized against the sum of
spiked-in positive controls and background corrected based on 2
standard deviations above the mean of the included negative con-
trols. A normalization factor based on the geometric mean of
miRNAs with the lowest coefficient of variation in expression
across the samples was applied to account for sample content var-
iability. To filter out lowly expressed miRNAs, the background
baseline level of 2 standard deviations above the mean of the
included negative controls was set as the cut-off value for expres-
sion. Using this cut-off, miRNAs with values falling below the
background baseline in more than 30% of the samples were con-
sidered unexpressed and removed from the analysis. As the levels
of environmental pollutants (PCBs, PBDEs, DDE, and BPA)
and metals (Hg, Pb, Cd) were not normally distributed, study
samples were categorized based on exposure levels; while organics
were quartiled, metals were dichotomized at the median due
to the reduced size of samples with measured metal content
(n D 43). A moderated t-test from the LIMMA package69 was
used to examine the mean miRNA expression differences based
on the highest and lowest quartiles for pollutants and above and
below the median level for metals. The cut-off value for BPA was
set at the detection level (42 samples below the limit of detection
and 21 samples above the limit of detection). The relationship
between organic pollutants and miRNA was further analyzed by
generalized linear model using the quartile-specific geometric
mean value of the organics as exposure variables due to the non-
linear nature of the relationship between miRNA expression level
and environmental pollutants. All analysis was conducted using
R 3.0.2 (http://www.r-project.org/). All statistical tests were
2-sided, and P < 0.05 was considered statistically significant.
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